3.62
price up icon2.55%   0.09
pre-market  プレマーケット:  3.68   0.06   +1.66%
loading
前日終値:
$3.53
開ける:
$3.55
24時間の取引高:
442.19K
Relative Volume:
0.76
時価総額:
$218.73M
収益:
$40.37M
当期純損益:
$-119.72M
株価収益率:
-1.7743
EPS:
-2.0402
ネットキャッシュフロー:
$-135.06M
1週間 パフォーマンス:
+9.04%
1か月 パフォーマンス:
-3.85%
6か月 パフォーマンス:
-15.02%
1年 パフォーマンス:
+16.03%
1日の値動き範囲:
Value
$3.55
$3.71
1週間の範囲:
Value
$3.26
$3.71
52週間の値動き範囲:
Value
$2.83
$5.55

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Name
名前
Voyager Therapeutics Inc
Name
セクター
Healthcare (1100)
Name
電話
857-259-5340
Name
住所
75 HAYDEN AVENUE, LEXINGTON, MA
Name
職員
141
Name
Twitter
@VoyagerTx
Name
次回の収益日
2026-08-05
Name
最新のSEC提出書
Name
VYGR's Discussions on Twitter

Compare VYGR vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
VYGR icon
VYGR
Voyager Therapeutics Inc
3.62 219.33M 40.37M -119.72M -135.06M -2.0402
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
458.99 114.33B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
607.93 64.47B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
892.26 54.99B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
282.72 38.42B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
157.77 34.03B 742.00K -1.37B -1.07B -7.0731

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 開始されました Cantor Fitzgerald Overweight
2024-12-02 開始されました Citigroup Buy
2024-11-29 再開されました Wedbush Outperform
2024-10-16 開始されました Leerink Partners Outperform
2024-03-26 開始されました Guggenheim Buy
2024-03-19 開始されました H.C. Wainwright Buy
2024-03-07 開始されました Citigroup Buy
2024-01-02 アップグレード Wells Fargo Equal Weight → Overweight
2023-05-10 開始されました Truist Buy
2023-03-10 開始されました Oppenheimer Outperform
2021-10-07 アップグレード Robert W. Baird Neutral → Outperform
2021-02-26 ダウングレード Robert W. Baird Outperform → Neutral
2021-02-03 ダウングレード BTIG Research Buy → Neutral
2021-02-03 ダウングレード Wedbush Outperform → Neutral
2020-12-24 ダウングレード Cantor Fitzgerald Overweight → Neutral
2020-12-23 ダウングレード Raymond James Outperform → Mkt Perform
2020-11-11 ダウングレード Oppenheimer Outperform → Perform
2020-11-10 ダウングレード Raymond James Strong Buy → Outperform
2020-11-10 ダウングレード Wells Fargo Overweight → Equal Weight
2020-03-19 開始されました The Benchmark Company Buy
2020-02-06 開始されました Oppenheimer Outperform
2018-11-15 アップグレード Raymond James Outperform → Strong Buy
2018-09-10 再開されました BTIG Research Buy
2018-09-10 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-06-04 開始されました H.C. Wainwright Buy
2018-03-12 ダウングレード Evercore ISI Outperform → In-line
2018-03-12 ダウングレード Wedbush Outperform → Neutral
2018-02-02 開始されました Morgan Stanley Overweight
2017-11-28 再開されました Piper Jaffray Overweight
2017-10-31 開始されました Robert W. Baird Outperform
2017-10-27 開始されました Canaccord Genuity Buy
2017-10-23 繰り返されました Stifel Buy
2017-10-12 開始されました Raymond James Outperform
2017-08-17 開始されました Evercore ISI Outperform
2017-07-28 再開されました Stifel Buy
すべてを表示

Voyager Therapeutics Inc (VYGR) 最新ニュース

pulisher
Jun 11, 2026

Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference - markets.businessinsider.com

Jun 11, 2026
pulisher
Jun 11, 2026

Voyager Therapeutics (VYGR) director awarded 30,000 stock options at $3.43 - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Voyager Therapeutics (VYGR) grants director 30,000 stock options at $3.43 - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Voyager Therapeutics director granted 30,000 options | VYGR Insider Trading - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Voyager director granted options for 30,000 shares | VYGR Insider Trading - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Voyager Therapeutics (VYGR) director receives 30,000 stock options grant - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Voyager Therapeutics (VYGR) director granted 30,000 stock options at $3.43 - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Voyager Therapeutics (VYGR) grants director Glenn Pierce 30,000 stock options - Stock Titan

Jun 11, 2026
pulisher
Jun 10, 2026

Voyager Therapeutics Expands Authorized Shares After Stockholder Vote - TipRanks

Jun 10, 2026
pulisher
Jun 10, 2026

Voyager Therapeutics (NASDAQ: VYGR) doubles authorized common stock after 2026 vote - Stock Titan

Jun 10, 2026
pulisher
Jun 09, 2026

Here's Why We're A Bit Worried About Voyager Therapeutics' (NASDAQ:VYGR) Cash Burn Situation - Yahoo Finance

Jun 09, 2026
pulisher
Jun 02, 2026

Guggenheim Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $22 - Moomoo

Jun 02, 2026
pulisher
Jun 02, 2026

Voyager’s tau-targeted gene therapy VY-1706 gains IND approval - BioWorld News

Jun 02, 2026
pulisher
Jun 02, 2026

Voyager gets FDA clearance for Alzheimer’s gene therapy trial By Investing.com - Investing.com India

Jun 02, 2026
pulisher
Jun 01, 2026

Voyager Therapeutics (VYGR) Gains FDA Approval for Alzheimer's G - GuruFocus

Jun 01, 2026
pulisher
Jun 01, 2026

Voyager Therapeutics Receives FDA Clearance to Begin Clinical Trial of VY1706 Gene Therapy for Alzheimer’s Disease - Minichart

Jun 01, 2026
pulisher
Jun 01, 2026

Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease - markets.businessinsider.com

Jun 01, 2026
pulisher
Jun 01, 2026

Voyager Therapeutics IND Cleared for Alzheimer’s Gene Therapy - TipRanks

Jun 01, 2026
pulisher
Jun 01, 2026

Voyager Therapeutics receives FDA clearance to begin Alzheimer’s gene therapy trial - Investing.com India

Jun 01, 2026
pulisher
Jun 01, 2026

FDA clears Voyager Therapeutics (VYGR) IND for Alzheimer’s gene therapy VY1706 - Stock Titan

Jun 01, 2026
pulisher
Jun 01, 2026

Voyager Receives FDA IND Clearance for VY1706, First Gene - GlobeNewswire

Jun 01, 2026
pulisher
May 27, 2026

Voyager Therapeutics Stock Is Waking Up Before a Make-or-Break Tau Window - Bez Kabli

May 27, 2026
pulisher
May 26, 2026

H.C. Wainwright Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $25 - Moomoo

May 26, 2026
pulisher
May 26, 2026

H.C. Wainwright reiterates Voyager Therapeutics stock rating on pipeline progress - Investing.com Australia

May 26, 2026
pulisher
May 26, 2026

H.C. Wainwright reiterates Voyager Therapeutics stock rating on pipeline progress By Investing.com - Investing.com South Africa

May 26, 2026
pulisher
May 23, 2026

Voyager Therapeutics Q1 2026 Earnings: Narrower‑than‑Expected Loss Drives Positive Stock Reaction - The Legal Advocate

May 23, 2026
pulisher
May 22, 2026

Voyager Therapeutics Inc. (VYGR) Q1 2026 Earnings: Narrowed Loss Meets Optimism in Gene Therapy PipelineEPS Consistency Score - Newser

May 22, 2026
pulisher
May 22, 2026

Voyager Therapeutics Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Market ResponseNet Income Trends - Newser

May 22, 2026
pulisher
May 22, 2026

Voyager Therapeutics (VYGR) Shares Rebound 4.76% as Biotech Sector Shows StrengthCrowd Risk Alerts - Newser

May 22, 2026
pulisher
May 20, 2026

- Insider Monkey

May 20, 2026
pulisher
May 20, 2026

What Voyager Therapeutics Inc (VYGR) Has Gained on Its Therapy Programs - Insider Monkey

May 20, 2026
pulisher
May 19, 2026

5 Best Gene Therapy Stocks to Buy in 2026 - Insider Monkey

May 19, 2026
pulisher
May 18, 2026

Voyager Therapeutics (VYGR) accounting officer reports initial share and option holdings - Stock Titan

May 18, 2026
pulisher
May 17, 2026

The one question every Voyager Therapeutics VYGR investor should ask Bullish Sentiment 20260510Weak Earnings Momentum - The Legal Advocate

May 17, 2026
pulisher
May 15, 2026

VYGR (NASDAQ: VYGR) affiliate files Form 144 to sell 25,000 shares - Stock Titan

May 15, 2026
pulisher
May 15, 2026

EcoR1 and Oleg Nodelman report 0 shares in Voyager (NASDAQ: VYGR) amendment - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Armistice Capital (VYGR) reports 3.5M shares, 5.87% stake in Voyager - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Voyager Therapeutics (NASDAQ: VYGR) affiliate files to sell 9,406 shares - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Wedbush Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $8 - Moomoo

May 15, 2026
pulisher
May 14, 2026

TradingKey - TradingKey

May 14, 2026
pulisher
May 14, 2026

VYGR Technical Analysis | Trend, Signals & Chart Patterns | VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) - ChartMill

May 14, 2026
pulisher
May 13, 2026

Voyager presents preclinical data for Alzheimer’s gene therapy By Investing.com - Investing.com India

May 13, 2026
pulisher
May 13, 2026

Voyager Therapeutics (VYGR) Reports Positive Findings for Alzhei - GuruFocus

May 13, 2026
pulisher
May 13, 2026

VYGR Secures Mission Management Contract for ISS Research - GuruFocus

May 13, 2026
pulisher
May 13, 2026

Voyager presents preclinical data for Alzheimer’s gene therapy - Investing.com UK

May 13, 2026
pulisher
May 13, 2026

Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026 - The Manila Times

May 13, 2026
pulisher
May 13, 2026

Voyager Therapeutics Advances VY1706 Gene Therapy for Alzheimer's Disease with IND Application on Track for Q2 2026 - Quiver Quantitative

May 13, 2026

Voyager Therapeutics Inc (VYGR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$31.20
price up icon 2.60%
$92.22
price up icon 3.04%
$53.70
price down icon 0.94%
$61.80
price up icon 11.55%
ONC ONC
$262.68
price down icon 0.47%
$157.77
price up icon 0.76%
大文字化:     |  ボリューム (24 時間):